Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today results from the Phase III persevERA Breast Cancer study evaluating investigational giredestrant in combination ...

Moeltner—on subsequent earnings calls. The company's product-mix flexibility allows for dynamic reallocation to segments with ...

VinFast (VFS) stock faces cash burn, credit stress, dilution risk and rich EV/Sales valuation amid fierce EV competition.

Immune-mediated adverse events following concomitant radiotherapy and immunotherapy in patients with melanoma and Merkel cell carcinoma: A preliminary report from an evolving retrospective registry.

PRINCETON, N.J., February 23, 2026--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced positive top-line results from the ongoing, ex-US, Phase 2 registrational study (NCT05664737) ...

– Verekitug provided statistically significant and clinically meaningful reductions in annualized asthma exacerbation rate (AAER) with 100 mg q12 and 400 mg q24 week dosing – – Verekitug also ...

WALTHAM, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe ...

Managing stress is crucial when you have EGFR-positive lung cancer, as chronic stress can negatively impact your body’s immune system and contribute to cancer growth and treatment resistance. Stress ...

Compare the best boxing betting sites and apps in 2026. Find top sportsbooks for boxing odds, fight props, live betting, and ...

Stay on This Page Pinned Feb 24, 2026 at 3:30 PM EST We are updating this story in real time as new information breaks. Stay on this page for the latest developments, key quotes, numbers, and market ...

"slightly offset by subscribers projected to be down seven percent year over year to 2,200,000." Management confirmed, "We expect adjusted EBITDA to be in a range of $10 million to $20 million in 2026 ...